Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis

E-ISSN： 1875-6190|7|1|60-64

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.7, Iss.1, 2009-03, pp. : 60-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple sclerosis and its treatment

By Giovannoni Gavin Miller David H

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 315-322

Royal College Of Physicians

Access to resources Recommend Favorite

Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emerging Concepts Regarding its Mechanism of Action

By Lalive Patrice H. Neuhaus Oliver

CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. : 401-414

Adis International

Access to resources Recommend Favorite

Uric acid: a novel treatment strategy for multiple sclerosis

By Mousavizadeh K. Dehpour A.R. Minagar A. Ghafourifar P.

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 563-564

Elsevier

Access to resources Recommend Favorite

Emerging therapies in multiple sclerosis

By Farrell Rachel Heaney Dominic Giovannoni Gavin

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 797-816

Informa Healthcare

Access to resources Recommend Favorite

The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment

By Phillips C.J.

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 561-574

Adis International

Access to resources Recommend Favorite